APA

Black L. E., Green J. D., Rener J., Dayan A., Cavagnaro J. A., Spindler P., Bussiere J. L., Bouchard P., Inoue T., Thomas P. T., Essayan D. M., Gillett N. A., Hart T. K., Hastings K., House R. V., Latta D., Liminga U., Treacy G. & Wierda D. (20000901). Safety evaluation of immunomodulatory biopharmaceuticals: can we improve the predictive value of preclinical studies?. : Human & experimental toxicology.

Chicago

Black L E, Green J D, Rener J, Dayan A, Cavagnaro J A, Spindler P, Bussiere J L, Bouchard P, Inoue T, Thomas P T, Essayan D M, Gillett N A, Hart T K, Hastings K, House R V, Latta D, Liminga U, Treacy G and Wierda D. 20000901. Safety evaluation of immunomodulatory biopharmaceuticals: can we improve the predictive value of preclinical studies?. : Human & experimental toxicology.

Harvard

Black L. E., Green J. D., Rener J., Dayan A., Cavagnaro J. A., Spindler P., Bussiere J. L., Bouchard P., Inoue T., Thomas P. T., Essayan D. M., Gillett N. A., Hart T. K., Hastings K., House R. V., Latta D., Liminga U., Treacy G. and Wierda D. (20000901). Safety evaluation of immunomodulatory biopharmaceuticals: can we improve the predictive value of preclinical studies?. : Human & experimental toxicology.

MLA

Black L E, Green J D, Rener J, Dayan A, Cavagnaro J A, Spindler P, Bussiere J L, Bouchard P, Inoue T, Thomas P T, Essayan D M, Gillett N A, Hart T K, Hastings K, House R V, Latta D, Liminga U, Treacy G and Wierda D. Safety evaluation of immunomodulatory biopharmaceuticals: can we improve the predictive value of preclinical studies?. : Human & experimental toxicology. 20000901.